Skip to main content
. 2013 Dec 13;2013(12):CD004975. doi: 10.1002/14651858.CD004975.pub3

Hoberman 1997.

Methods Multicentre, randomised, non‐placebo‐controlled trial conducted at 4 university‐affiliated hospitals and 20 private practices in the US and Canada between January and July 1994
AOM was defined as either presence of purulent otorrhoea for less than 24 hours or evidence of middle ear effusion in addition to at least 1 indicator of acute middle ear inflammation
Investigators were blinded to treatment assignments and participants, parents and guardians were asked not to discuss medications or duration of treatment with investigators
Participants 575 children aged 2 months to 12 years were included (287 and 288 in the 2 and 3 times daily groups, respectively)
Interventions 10 days of amoxicillin/clavulanate 40/10 mg/kg/day 2 times daily versus 45/6.4 mg/kg/day 3 times daily
Outcomes Primary outcome
1. Clinical cure rate at the end of therapy (days 7 to 15)
‐ Clinical cure (completely/improved symptoms and signs of AOM at days 12 to 14
Secondary outcomes  
1. Clinical cure rate during therapy (days 2 to 3), in terms of resolution of otalgia and resolution of fever: not accounted
2. Clinical cure rate at post‐treatment (1 to 3 months): clinical cure at days 31 to 38
3. AOM complications after completion of therapy: recurrent AOM
4. Adverse reactions to medication
 ‐ Adverse events: diaper rash: vomiting, diarrhoea
Other outcome
‐ Compliance rate
Notes Supported by SmithKline Beecham Pharmaceuticals
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "assigned randomly"
Comment: method of randomisation was not mentioned
Allocation concealment (selection bias) Unclear risk Quote: "Investigators were blinded to treatment assignments"
Comment: no information on the allocation concealment
Blinding (performance bias and detection bias) 
 All outcomes Low risk Quote: "..parents and guardians were asked not to discuss medications or duration of treatment with investigators"
Comment: probably done
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No loss to follow‐up
Selective reporting (reporting bias) Low risk All important outcomes were accounted for
Other bias Low risk Quote: "Comparable demographic data and compliance rate"